---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-24-000738"
form_type: "8-K"
ticker: "LCTC"
cik: "0001493137"
company_name: "Lifeloc Technologies, Inc"
filed_at: "2024-05-15T23:59:59+00:00"
generated_at: "2026-06-01T22:56:57.663009+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.72
calibrated_materiality_score: 0.72
confidence: "high"
source: SEC EDGAR
---

# Lifeloc Q1 net loss widens to $284K; revenue flat at $2.15M

## Summary
- Net revenue $2.153M flat YoY ($2.165M); net loss $(284)K ($0.12/diluted) vs $(54)K loss ($0.02/sh).
- Gross margin declined to 38.8% from 43.2% due to inflation-driven cost increases.
- R&D spending rose 40% primarily for SpinDx drug testing platform development.
- Beta testing of SpinDx saliva THC detection expected later in 2024; commercial launch projected 2025.
- Smartphone pairing for LX9 breathalyzer expected in Q2 2024.

## SEC filing metadata
- accession: 0001079973-24-000738
- form_type: 8-K
- ticker: LCTC
- cik: 0001493137
- company_name: Lifeloc Technologies, Inc
- filed_at: 2024-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.72
- calibrated_materiality_score: 0.72
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1493137/000107997324000738/0001079973-24-000738-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1493137/000107997324000738/lclc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-24-000738
- JSON: https://secwatch.observer/filing/0001079973-24-000738.json
- Plain text: https://secwatch.observer/filing/0001079973-24-000738.txt

## Key facts
- Earnings Releases
  Lifeloc Technologies, Inc reported first quarter ended March 31, 2024 results: revenue $2.153 million, net income $(284) thousand, EPS $(0.12) per diluted share.
  - Period: first quarter ended March 31, 2024
  - Revenue: $2.153 million
  - Net income: $(284) thousand
  - EPS: $(0.12) per diluted share
  - Result: reported results
  source text: Lifeloc posted quarterly net revenue of $2.153 million resulting in a quarterly net loss of $(284) thousand, or $(0.12) per diluted share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1493137/000107997324000738/0001079973-24-000738-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.